Kazia Therapeutics Limited (KZIA)
NASDAQ·Healthcare·Biotechnology
$12.14
-4.33%
Mkt Cap $13.31M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$28.50
Range $25.00 – $32.00
Implied Upside
+134.8%
Consensus $28.50 vs current $12.14
NASDAQ·Healthcare·Biotechnology
$12.14
-4.33%
Mkt Cap $13.31M
No recent rating data.
Price Target (4 analysts)
$28.50
Range $25.00 – $32.00
+134.8%
Consensus $28.50 vs current $12.14